Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.220
+0.010 (0.83%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $44.46 million as of July 15, 2026. Its market cap has increased by 49.18% in one year.
Market Cap
44.46M
Enterprise Value
43.90M
1-Year Change
49.18%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $44.46M, a decrease of -53.11%. That is a compound annual growth rate of -9.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 44.46M | 30.75% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aligos Therapeutics | 39.73M |
| RenovoRx | 39.69M |
| Grace Therapeutics | 39.06M |
| Estrella Immunopharma | 37.91M |
| NanoViricides | 36.45M |
| Actuate Therapeutics | 35.89M |
| Nutriband | 35.74M |
| BriaCell Therapeutics | 34.33M |